Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Gary D. Tollefson
JCP
Original Research
Comparison of Risperidone and Olanzapine in the Control of Negative Symptoms of Chronic Schizophrenia and Related Psychotic Disorders in Patients Aged 50 to 65 Years
JCP
Article
Concluding Remarks
JCP
Article
Efficacy of Olanzapine: An Overview of Pivotal Clinical Trials
JCP
Article
Evidence for the Effectiveness of Olanzapine Among Patients Nonresponsive and/or Intolerant to Risperidone
JCP
Original Research
Extrapyramidal Symptoms and Tolerability of Olanzapine Versus Haloperidol in the Acute Treatment of Schizophrenia
JCP
Original Research
Factors Influencing Acute Weight Change in Patients With Schizophrenia Treated With Olanzapine, Haloperidol, or Risperidone
JCP
Original Research
Long-Term Olanzapine Treatment: Weight Change and Weight-Related Health Factors in Schizophrenia
JCP
Original Research
Olanzapine/Fluoxetine Combination for Treatment-Resistant Depression: A Controlled Study of SSRI and Nortriptyline Resistance
JCP
Article
Safety of Olanzapine
JCP
Article
Should We Consider Mood Disturbance in Schizophrenia as an Important Determinant of Quality of Life?
